Company Profile Boards & Staffs Memberships & Partners Academy of Journalism Careers Blog(EN)Contact Us

Our Journals Instruction for Authors Brieflands Policies Publish My Research Journal Management System Article Processing Charges Open Peer Review Publishing Services

Publish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Current Issue Accepted Manuscripts All Issues In Press Articles Search

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

Crossref

1. MicroRNA-26a–interleukin (IL)-6–IL-17 axis regulates the development of non-alcoholic fatty liver disease in a murine model

- Q He

- F Li

- J Li

- R Li

- G Zhan

- G Li

- W Du

- H Tan

2. Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease

- Saira Rafaqat

- Sanja Gluscevic

- Filiz Mercantepe

- Sana Rafaqat

- Aleksandra Klisic

3. Branched chain amino acids supplementation modulates TGF‐β1/Smad signaling pathway and interleukins in CCl4‐induced liver fibrosis

- Naglaa F. Khedr

- Eman G. Khedr

4. Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency

- Myungsuk Kim

- GyHye Yoo

- Ahmad Randy

- Hyoung Seok Kim

- Chu Won Nho

5. Integrated bioinformatics analysis reveals potential mechanisms associated with intestinal flora intervention in nonalcoholic fatty liver disease

- Yingying Liu

- Xinkui Liu

- Wei Zhou

- Jingyuan Zhang

- Jiarui Wu

- Siyu Guo

- Shanshan Jia

- Haojia Wang

- Jialin Li

- Yingying Tan

6. Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico

- Omar Ramos-Lopez

7. Hepatoprotective Effect of Antrodia cinnamomea Mycelium in Patients with Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial

- Ya-Ling Chiou

- Charng-Cherng Chyau

- Tsung-Ju Li

- Chia-Feng Kuo

- Yu-Yling Kang

- Chin-Chu Chen

- Wang-Sheng Ko

8. Gut microbiota, fatty liver disease, and hepatocellular carcinoma

- Huikuan Chu

- Brandon Williams

- Bernd Schnabl

9. Caspase 3, 6, 8, and 9 Gene Expression in Peripheral Blood Leukocytes and Plasma Concentrations of IL-6 and TNF-α in Carriers of Different Polymorphic Marker -174G>C Genotypes of IL6 Gene Associated with the Risk of Nonalcoholic Steatohepatitis

- I. V. Kurbatova

- L. V. Topchieva

- O. P. Dudanova

10. Cytokines Genotype‐Phenotype Correlation in Nonalcoholic Steatohepatitis

- Ioana Corina Bocsan

- Mircea Vasile Milaciu

- Raluca Maria Pop

- Stefan Cristian Vesa

- Lorena Ciumarnean

- Daniela Maria Matei

- Anca Dana Buzoianu

- Giuseppe Valacchi

11. Celastrus orbiculatus Thunb. extracts and celastrol alleviate NAFLD by preserving mitochondrial function through activating the FGF21/AMPK/PGC-1α pathway

- Junli Xue

- Yunchao Liu

- Boyan Liu

- Xiubin Jia

- Xinsheng Fang

- Shucun Qin

- Ying Zhang